Exact Sciences
EXAS
#1548
Rank
HK$86.81 B
Marketcap
HK$469.10
Share price
-0.63%
Change (1 day)
-6.93%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2024 (TTM): -HK$1.5 Billion

According to Exact Sciences's latest financial reports the company's current earnings are HK$2.69 Billion. In 2023 the company made an earning of -HK$1.48 Billion, an increase over its 2022 earnings that were of -HK$4.8 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$1.5 Billion1.52%
2023 -HK$1.48 Billion-69.28%
2022 -HK$4.8 Billion-25.55%
2021 -HK$6.45 Billion1.68%
2020 -HK$6.35 Billion271.17%
2019 -HK$1.71 Billion58.99%
2018 -HK$1.08 Billion20.89%
2017 -HK$0.89 Billion-30.95%
2016 -HK$1.29 Billion5.09%
2015 -HK$1.23 Billion57.24%
2014 -HK$0.78 Billion116.53%
2013 -HK$0.36 Billion
2011 -HK$0.23 Billion143.73%
2010 -HK$91.9 Million27.85%
2009 -HK$71.88 Million0.27%
2008 -HK$71.69 Million-20.95%
2007 -HK$90.69 Million-13.53%
2006 -HK$0.11 Billion-10.07%
2005 -HK$0.12 Billion-21.81%
2004 -HK$0.15 Billion-33.44%
2003 -HK$0.23 Billion-6.51%
2002 -HK$0.24 Billion17.95%
2001 -HK$0.21 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$0.89 Billion-40.71%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.51 B-134.38%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$63.47 Million-95.74%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$0.28 Billion-81.75%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$57.56 B-3,966.20%๐Ÿ‡ซ๐Ÿ‡ท France